Enfermedades neurodegenerativas: mecanismos patogénicos
Buscador de publicaciones
Sólo se han incluido artículos originales, editoriales y revisiones.
-
Maroto IB, Costas-Insua C, Montero-Fernández C, Hermoso-López A, Lebouc M, Bajo-Grañeras R, Álvaro-Blázquez A, Blázquez C, Cannich A, Marsicano G, Martín R, Baufreton J, Rodríguez-Crespo I, Bellocchio L, Guzmán M.
GAP43 Located on Corticostriatal Terminals Restrains Novelty-Induced Hyperactivity in Mice.
JOURNAL OF NEUROSCIENCE . 44(39): .
-
Quintero JM, Diaz LE, Galve-Roperh I, Bustos RH, Leon MX, Beltran S, Dodd S.
The endocannabinoid system as a therapeutic target in neuropathic pain: a review.
EXPERT OPINION ON THERAPEUTIC TARGETS . 28(9): 739-755. Nº de citas: 1
-
Costas-Insua C, Hermoso-López A, Moreno E, Montero-Fernández C, Álvaro-Blázquez A, Maroto IB, Sánchez-Ruiz A, Diez-Alarcia R, Blázquez C, Morales P, Canela EI, Casadó V, Urigüen L, Perea G, Bellocchio L, Rodríguez-Crespo I, Guzmán M.
The CB(1) receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls.
EMBO MOLECULAR MEDICINE . 16(4): 755-783.
-
Tundidor I, Seijo-Vila M, Blasco-Benito S, Rubert-Hernández M, Moreno-Bueno G, Bindila L, de la Rosa RF, Guzmán M, Sánchez C, Pérez-Gómez E.
Fatty acid amide hydrolase drives adult mammary gland development by promoting luminal cell differentiation.
Cell death discovery . 10(1): 12-12.
-
Maroto IB, Moreno E, Costas-Insua C, Merino-Gracia J, Diez-Alarcia R, Álvaro-Blázquez A, Canales Á, Canela EI, Casadó V, Urigüen L, Rodríguez-Crespo I, Guzmán M.
Selective inhibition of cannabinoid CB(1) receptor-evoked signalling by the interacting protein GAP43.
Neuropharmacology . 240: 109712-109712.
-
Espina M, Di Franco N, Brañas-Navarro M, Navarro IR, Brito V, Lopez-Molina L, Costas-Insua C, Guzmán M, Ginés S.
The GRP78-PERK axis contributes to memory and synaptic impairments in Huntington's disease R6/1 mice.
NEUROBIOLOGY OF DISEASE . 184: 106225-106225.
-
Tundidor I, Seijo-Vila M, Blasco-Benito S, Rubert-Hernández M, Adámez S, Andradas C, Manzano S, Álvarez-López I, Sarasqueta C, Villa-Morales M, González-Lois C, Ramírez-Medina E, Almoguera B, Sánchez-López AJ, Bindila L, Hamann S, Arnold N, Röcken C, Heras-Murillo I, Sancho D, Moreno-Bueno G, Caffarel MM, Guzmán M, Sánchez C, Pérez-Gómez E.
Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer.
NATURE COMMUNICATIONS . 14(1): 3130-3130.
-
Costas-Insua C, Seijo-Vila M, Blázquez C, Blasco-Benito S, Rodríguez-Baena FJ, Marsicano G, Pérez-Gómez E, Sánchez C, Sánchez-Laorden B, Guzmán M.
Neuronal Cannabinoid CB(1) Receptors Suppress the Growth of Melanoma Brain Metastases by Inhibiting Glutamatergic Signalling.
Cancers . 15(9): .
-
Maroto IB, Costas-Insua C, Berthoux C, Moreno E, Ruiz-Calvo A, Montero-Fernández C, Macías-Camero A, Martín R, García-Font N, Sánchez-Prieto J, Marsicano G, Bellocchio L, Canela EI, Casadó V, Galve-Roperh I, Núñez Á, Fernández de Sevilla D, Rodríguez-Crespo I, Castillo PE, Guzmán M.
Control of a hippocampal recurrent excitatory circuit by cannabinoid receptor-interacting protein Gap43.
NATURE COMMUNICATIONS . 14(1): 2303-2303. Nº de citas: 1
-
Costas-Insua C, Guzmán M.
Endocannabinoid signaling in glioma
Glia . 71(1): 127-138. Nº de citas: 3
-
Manterola A, Chara JC, Aguado T, Palazuelos J, Matute C, Mato S.
Cannabinoid CB(1) receptor expression in oligodendrocyte progenitors of the hippocampus revealed by the NG2-EYFP-knockin mouse.
FRONTIERS IN NEUROANATOMY . 16: 1030060-1030060.
-
Sánchez-de la Torre A, Aguado T, Huerga-Gómez A, Santamaría S, Gentile A, Chara JC, Matute C, Monory K, Mato S, Guzmán M, Lutz B, Galve-Roperh I, Palazuelos J.
Cannabinoid CB(1) receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice.
CELL DEATH & DISEASE . 13(7): 585-585. Nº de citas: 1
-
McAllister SD, Abood ME, Califano J, Guzmán M.
Cannabinoid Cancer Biology and Prevention.
Journal of the National Cancer Institute. Monographs . 2021(58): 99-106.
-
Gómez-Almería M, Burgaz S, Costas-Insua C, Rodríguez-Cueto C, Santos-García I, Rodríguez-Crespo I, García C, Guzmán M, de Lago E, Fernández-Ruiz J.
BiP Heterozigosity Aggravates Pathological Deterioration in Experimental Amyotrophic Lateral Sclerosis
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 22(22): . Nº de citas: 2
-
Aguado, Tania, Huerga-Gomez, Alba, Sanchez-de la Torre, Anibal, Resel, Eva, Chara, Juan Carlos, Matute, Carlos, Mato, Susana, Galve-Roperh, Ismael, Guzman, Manuel, Palazuelos, Javier.
Delta(9)-Tetrahydrocannabinol promotes functional remyelination in the mouse brain
BRITISH JOURNAL OF PHARMACOLOGY . 178(20): 4176-4192. Nº de citas: 6
-
Costas-Insua C, Moreno E, Maroto IB, Ruiz-Calvo A, Bajo-Grañeras R, Martín-Gutiérrez D, Diez-Alarcia R, Vilaró MT, Cortés R, García-Font N, Martín R, Espina M, Botta J, Ginés S, McCormick PJ, Sánchez-Prieto J, Galve-Roperh I, Mengod G, Urigüen L, Marsicano G, Bellocchio L, Canela EI, Casadó V, Rodríguez-Crespo I, Guzmán M.
Identification of BiP as a CB(1) receptor-interacting protein that fine-tunes cannabinoid signaling in the mouse brain.
JOURNAL OF NEUROSCIENCE . 41(38): 7924-7941. Nº de citas: 7
-
Maglio, Laura E., Noriega-Prieto, Jose A., Maroto, Irene B., Martin-Cortecero, Jesus, Muñoz-Callejas A, Callejo-Mostoles, Marta, Fernandez de Sevilla, David.
IGF-1 facilitates extinction of conditioned fear
ELIFE . 10: . Nº de citas: 12
-
Huerga-Gomez, Alba, Aguado, Tania, Sanchez-de la Torre, Anibal, Bernal-Chico, Ana, Matute, Carlos, Mato, Susana, Guzman, Manuel, Galve-Roperh, Ismael, Palazuelos, Javier.
Delta(9)-Tetrahydrocannabinol promotes oligodendrocyte development and CNS myelination in vivo
Glia . 69(3): 532-545. Nº de citas: 15